ILMN Illumina PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ILMN
- PE Ratio
As of Aug 12, 2025, the Illumina stock's P/E ratio is 12.3. This takes into account the latest EPS of $7.92 and stock price of $97.38.
ILMN PE ratio history
The PE ratio of Illumina has averaged 57.45 over the last ten years. The current price-to-earnings ratio of 12.3 is 79% less than the historical average. Analyzing the last ten years, ILMN's PE ratio reached its highest point in the Jul 2021 quarter at 90.25, when the price was $474.73 and the EPS was $5.26. The lowest point was recorded in the Jun 2025 quarter, when it reached 11.97 with a price of $94.79 and an EPS of $7.92.
Illumina PE ratio by year
Maximum annual increase: 147.99% in 2013
Maximum annual decrease: -34.67% in 2014
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $135.27 | -$7.69 |
| 2023 | N/A | N/A | $139.24 | -$7.34 |
| 2023 | N/A | N/A | $202.2 | -$28 |
| 2022 | 75.04 | -9.14% | $380.44 | $5.07 |
| 2021 | 82.59 | 69.28% | $370 | $4.48 |
| 2019 | 48.79 | -7.89% | $332.29 | $6.81 |
| 2018 | 52.97 | 20.25% | $298.23 | $5.63 |
| 2017 | 44.05 | 6.3% | $218.49 | $4.96 |
| 2017 | 41.44 | -31.13% | $128.04 | $3.09 |
| 2016 | 60.17 | -16.56% | $191.95 | $3.19 |
| 2014 | 72.11 | -34.67% | $188.2 | $2.61 |
| 2013 | 110.38 | 147.99% | $110.38 | $1 |
| 2012 | 44.51 | 2.23% | $54.75 | $1.23 |
| 2012 | 43.54 | -30.57% | $30.48 | $0.7 |
| 2011 | 62.71 | 20.6% | $63.34 | $1.01 |
Illumina PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 11.97 | N/A | $94.79 | $7.92 |
| Mar 2025 | N/A | N/A | $80 | -$6.05 |
| Dec 2024 | N/A | N/A | $135.27 | -$7.69 |
| Sep 2024 | N/A | N/A | $130.12 | -$9.95 |
| Jun 2024 | N/A | N/A | $104.38 | -$19.15 |
| Mar 2024 | N/A | N/A | $137.32 | -$8.15 |
| Dec 2023 | N/A | N/A | $139.24 | -$7.34 |
| Oct 2023 | N/A | N/A | $137.28 | -$7.1 |
| Jul 2023 | N/A | N/A | $187.49 | -$26.59 |
| Apr 2023 | N/A | N/A | $232.55 | -$28.51 |
| Jan 2023 | N/A | N/A | $202.2 | -$28 |
| Oct 2022 | N/A | N/A | $190.79 | -$26.43 |
| Jul 2022 | N/A | N/A | $191.04 | -$0.08 |
| Apr 2022 | 79.28 | 5.65% | $363.9 | $4.59 |
| Jan 2022 | 75.04 | 16.5% | $380.44 | $5.07 |
ILMN Price vs fair value
ILMN average PE ratio chart
Currently, ILMN's PE ratio is under its 5 and 10-year averages.
ILMN PE vs peers
When compared to its peer stocks TMO and DHR, ILMN's PE ratio is lower. Illumina's PE ratio is trading below the peer average of 30.25.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ILMN Illumina Inc | 12.66 | $15.41B |
| DGX Quest Diagnostics Inc | 21.08 | $19.96B |
| TMO Thermo Fisher Scientific Inc | 27.99 | $183.07B |
| A Agilent Technologies Inc | 29.43 | $34.02B |
| DHR Danaher Corp | 43.95 | $148.84B |
| PACB Pacific Biosciences Of California Inc | N/A | $397.99M |
Frequently asked questions
What is Illumina's PE ratio?
As of Aug 12, 2025, ILMN stock has a price to earnings ratio of 12.3.
What is the 5-year average PE ratio for Illumina (ILMN)?
The 5-year average PE ratio for ILMN stock is 70.25.
What is the highest PE ratio for ILMN?
Over the last ten years, the quarterly PE ratio reached its highest level at 90.25 in the Jul 2021 quarter.
How does the current PE ratio for ILMN compare to its historical average?
ILMN's price to earnings ratio is currently 79% below its 10-year historical average.
How is ILMN's PE ratio calculated (Illumina PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 12, 2025), Illumina's share price is $97.38. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $7.92. Therefore, Illumina's price to earnings ratio for today is 12.3. PE RATIO(12.3) = STOCK PRICE($97.38) / TTM EPS($7.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.